Jan. 15-25, 2015
Cleveland Clinic Piloting ‘Adaptive Therapy’ Approach in Multiple Myeloma
The ASCO Post – Jan. 25
While an overall survival advantage has not yet been observed, a higher risk of side effects and higher costs have clearly been demonstrated, they noted. In cytogenetically high-risk patients, use of three drugs for induction actually reduced overall survival in a retrospective analysis from Moffitt Cancer Center, they added.
Editorial: Efforts to build a community in area around USF, Busch Gardens deserve support
The Tampa Tribune – Jan. 23
Yet the area is home to a number of high-profile institutions — USF, Busch Gardens, Moffitt Cancer Center and Florida Hospital — that contribute millions to the local economy, employ thousands of workers and in some instances provide some of the area’s highest wages.
Use of Hormonal Contraceptives Linked to Brain Cancer
Medscape – Jan. 22
Kathleen M. Egan, ScD, from the cancer epidemiology program at the H. Lee Moffitt Cancer Center in Tampa, Florida, agrees. “Glioma is rare in young women. Nonetheless, as oral contraceptive use is common in this age group, it will be important that additional studies are done to validate the findings,” said Dr Egan, who was not involved in the study.
Liposome Injection CPX-351 Receives Fast Track Designation for Relapsed AML
OncLive – Jan. 22
“AML patients treated with CPX-351 had a higher likelihood of remission, without evidence of increased early mortality, than patients treated with standard chemotherapy. In addition, CPX-351 led to longer survival in the large subset of patients whose AML arose out of a previously diagnosed hematologic disorder or a history of prior cytotoxic treatment, commonly referred to as secondary AML,” said lead author Jeffrey Lancet, MD, section chief of Leukemia at the H. Lee Moffitt Cancer Center and Research Institute, in a statement released when the results were published.
Tampa Innovation Alliance Aims to Redevelop USF Area
WUSF News “University Beat” – Jan. 21
The Tampa Innovation Alliance was formed by anchor members USF, Moffitt Cancer Center, Busch Gardens and Florida Hospital Tampa in 2011. But the group only really stepped up its activities since bringing Sharpe on board last summer after his tenure on the Hillsborough County Commission ended due to term limits.
Moffitt Develops PLA to Diagnose Lung Cancer
Lung Cancer News Today – Jan. 21
Moffitt Cancer Center researchers are working to aid patients with lung cancer by developing new strategies for screening and generating prognoses.
HPV: The Teen Vaccine No One Gets?
KSAT (San Antonia) via Ivanhoe Broadcast News – Jan. 21
But according to new research from the Moffitt Cancer Center, the HPV vaccine isn't as popular as it should be especially among boys. “It feels like a little bit, we've fallen short,” Susan Vadaparampil, Ph.D., professor and senior member of the Moffitt Cancer Center, told Ivanhoe.
Protein analysis method could act as new cancer biomarker
Fierce Diagnostics – Jan. 21
Researchers at Florida’s Moffitt Cancer Center are gaining deeper insight into the biological processes going on inside a tumor in an effort to battle cancer more effectively. They’ve developed a new technique to analyze specific protein complexes in cancer specimens.
COLUMN MLK’s children tarnishing his legacy
The Tampa Tribune – Jan. 18
For about the last five years I’ve been a volunteer with the American Cancer Society’s Road to Recovery program, which transports patients to and from treatments. Along the way I’ve met people from many backgrounds. One woman who I drove to Moffitt one day had worked for years in a probate court in a New York county.
HPV VACCINE NOT AS POPULAR AS IT SHOULD BE: STUDY
KABC-TV (Los Angeles) via Ivanhoe Broadcast News – Jan. 17
But according to new research from the Moffitt Cancer Center, the HPV vaccine isn’t as popular as it should be – especially among boys. “It feels a little bit like we’ve fallen short,” said Susan Vadaparampil, a professor and senior member of the Moffitt Cancer Center.
In Tampa Bay economy, 20 bullish signs for a stronger 2015
Tampa Bay Times – Jan. 16
This month, Moffitt Cancer Center unveiled plans to build a bigger hospital on its densely packed USF campus site by going higher. A 12-story facility will replace the five-story hospital there now — the latest tangible sign that demand for Moffitt's cancer-fighting prowess is booming.
Which Florida specialty license plate had the biggest growth in 2014?
Orlando Sentinel – Jan. 16
Closer to fruition are three plates passed by the Legislature last year and only began presales on Oct. 1, 2014. They have until Sept. 30, 2016 to reach the 1,000-presale threshold and all have made decent starts. As of Jan. 5, a plate for Moffitt Cancer Center leads the way with 731 presales followed by a plate for the Florida Sheriffs Association with 531 presales and then the Fallen Law Enforcement Officers plate with 431 presales.
Moffitt Looking at Expansion Options
WUSF News – Jan. 16
It's in the very early stages, but officials with the Moffitt Cancer Center are looking at expanding or rebuilding their main hospital. According to Moffitt Chief Operating Officer Jack Kolosky, nothing has been decided yet, but they know they need to do something to address hospital overcrowding.
The Link between Cancer and Infections: Moffitt Cancer Center’s Approach to Better Understanding and Preventing Cancer
Florida MD – Jan. 16
The Center for Infection Research in Cancer (CIRC) at Moffitt Cancer Center is a global leader in research focused on infections that cause cancer.
Duke Scientist: I Hope NCI Doesn’t Get Original Data
The Cancer Letter – Jan. 16
Topotecan played a crucial role in the Duke scandal. Its signature was cited in the paper the Duke group had published in Nature Medicine in 2006. In that paper, validation of signatures was reported for a set of ovarian tumors. These samples were part of a larger cohort—some from Duke and others from the H. Lee Moffitt Cancer Center.
Health officials: HPV vaccine is about stopping cancer, not promoting sex
Tampa Bay Times – Jan. 15
It’s time to try a new sales pitch, said national health leaders gathered at Moffitt Cancer Center on Thursday for a major conference on HPV, or human papillomavirus. “We need to start talking about it as a cancer vaccine, instead of a vaccine for sexually transmitted disease,” said Dr. Otis Brawley, chief medical officer of the American Cancer Society.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.
Please click here to view news releases featuring the cancer center.